Arkolith/Insider Trading/NUVB/Form 4

Sauvage Philippe

Chief Financial OfficerNuvation Bio Inc. (NUVB) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)40K$2.17$87K54K
Jul 15, 2026Option exercise(M)1$1.97$254K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Option exercise(M)40K—$0662K
Jul 15, 2026Option exercise(M)1—$0500K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002039891-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML